A Survey of Preconceptional Folic Acid Use in a Group of Canadian Women

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 3, 2005, Pages 232-236

  Tam, Larissa E ^a   McDonald, Sarah D ^b   Wen, Shi Wu ^b   Smith, Graeme N ^c   Windrim, Rory C ^d   Walker, Mark C ^b  

^a SCARBOROUGH HOSPITAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Congenital anomalies; Folic acid; Neural tube defect; Pregnanacy; Supplementation; Survey

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CANADA; CANADIAN; CONGENITAL MALFORMATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG INFORMATION; EDUCATIONAL STATUS; ENGLISH (LANGUAGE); ETHNICITY; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; INCOME; JUDAISM; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PATIENT EDUCATION; PREDICTION; PREPREGNANCY CARE; PUERPERIUM; RISK FACTOR; TELEVISION; UNIVARIATE ANALYSIS; UNPLANNED PREGNANCY; URBAN POPULATION; VITAMIN SUPPLEMENTATION; ATTITUDE TO HEALTH; ETHNIC GROUP; PREGNANCY; PRENATAL CARE; QUESTIONNAIRE;

CANADA; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; FOLIC ACID; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES; URBAN POPULATION;

EID: 21744442936     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30515-1     Document Type: Article

References (25)

1. Periconceptional use of folie acid for reduction of the risk of neural tube defects. Paediatrics & Child Health 1997, 2(2):152-154. Canadian Paediatric Society.
2. Woolf SH, Batrista RN, Angerson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, Canada Communication Group, Ottawa.
3. Folic acid for the prevention of neural tube defects. Pediatries 1993, 92:493-494. American Academy of Pediatries.
4. Po licy statement: folic acid and pregnancy, 1994. ACMG Newsletter 1995, 4:9-10. American College of Medical Genetics.
5. Folic acid for the prevention of recurrent neural tube defects 1993, American College of Obstetricians and Gynecologists, American College of Obstetricians and Gynecologists, Washington (DC).
6. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992, 41(RR14):1-7. Centers for Disease Control.
7. Wilson RD SOGC Clinical Practice Guidelines: the use of folic acid for the prevention of neural tube defects and other congenital anomalies. JOGC 2003, 138:1-7.
8. Castilla EE, Dutra MG Folate awareness among South American women. Lancet 1997, 349(9053):735.
9. Bekkers RL Eskes TK. Periconceptional folic acid intake in Nijmegen, Netherlands. Lancet 1999, 353(9149):292.
10. Ray JG, Singh G, Burrows RF Evidence for suboptimal use of periconceptional folic acid supplements globally. Br J Obstet Gynaecol 2004, 111(5):399-408.
11. Perlow JH Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient populations in Phoenix and Yuma, Arizona. Am J Obstet Gynecol 2001, 184(6):1263-1266.
12. Kloeblen AS Folate knowledge, intake from fortified grain products, and periconceptional supplementation patterns of a sample of low-income pregnant women according to the Health Belief Model. J Am Diet Assoc 1999, 99(1):33-38.
13. guidelines for the child-bearing years 1999, Health Canada. Nutrition for a healthy pregnancy, Minister of Public Works and Government Services Canada, Ottawa.
14. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 2002, 167(3):237-240.
15. Persad VL, Van den Hof MC, Dube JM, Zimmer P Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002, 167(3):241-245.
16. McGovern E, Moss H, Grewal G, Taylor A, Bjomsson S, Pell J Factors affecting the use of folic acid supplements in pregnant women in Glasgow. Br J Gen Pract 1997, 47(423):635-637.
17. Silberg J, Board P, Pratt L, Bodurtha. J. College women's awareness and consumption of folic acid for the prevention of neural tube defects. Genet Med 2000, 2(4):209-213. Quillin JM.
18. Morin VI, Mondor M, Wilson RD Knowledge on periconceptional use of folic acid in women of British Columbia. Fetal Diagn Ther 2001, 16(2):111-115.
19. Zhang J, Yu KF What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998, 280(19):1690-1691.
20. Howell SR, Barnett AG, Underwood MR The use of pre-conceptional folic acid as an indicator of uptake of a health message amongst white and Bangladeshi women in Tower Hamlets, east London. Fam Pract 2001, 18(3):300-303.
21. Ray JG, Vermeulen MJ, Meier C, Cole DE, Wyatt PR Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 2004, 171(4):343-345.
22. Mathews F, Yudkin P, Neil A Folates in the periconceptional period: are women getting enough?. Br J Obstet Gynaecol 1998, 105(9):954-959.
23. Rosenberg KD, Gelow JM, Sandoval AP Pregnancy intendedness and the use of periconceptional folic acid. Pediatries 2003, 111(5 Part 2):1142-1145.
24. Neimanis IM, Paterson JM, Bain E Preventing neural tube defects. Survey of preconceptional use of folic acid. Can Fam Physician 1999, 45:1717-1722.
25. French MR, Barr SI, Levy-Milne R Folate intakes and awareness of folate to prevent neural tube defects: a survey of women living in Vancouver, Canada. J Am Diet Assoc 2003, 103(2):181-185.